Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.7 USD -0.74%
Market Cap: 795.6m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Wall Street
Price Targets

ABCL Price Targets Summary
Abcellera Biologics Inc

Wall Street analysts forecast ABCL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABCL is 15.74 USD with a low forecast of 5.05 USD and a high forecast of 29.4 USD.

Lowest
Price Target
5.05 USD
87% Upside
Average
Price Target
15.74 USD
483% Upside
Highest
Price Target
29.4 USD
989% Upside

ABCL Last Price Targets
Abcellera Biologics Inc

The latest public price target was made on Nov 5, 2024 by Gary Nachman from BMO Capital , who expects ABCL stock to rise by 85% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Gary Nachman
BMO Capital
5 USD
Upside 85%
3 days ago
Nov 5, 2024
AbCellera Biologics (ABCL) PT Lowered to $5 at BMO Capital
StreetInsider
Scott Schoenhaus
KeyBanc
5 USD
Upside 85%
2 months ago
Aug 23, 2024
KeyBanc Reiterates Overweight Rating on AbCellera Biologics (ABCL)
StreetInsider
Scott Schoenhaus
KeyBanc
7 USD
Upside 159%
6 months ago
May 8, 2024
AbCellera Biologics (ABCL) PT Lowered to $7 at KeyBanc
StreetInsider
Gary Nachman
BMO Capital
Price Target 5 USD
Upside/Downside 85%
View Source
Scott Schoenhaus
KeyBanc
Price Target 5 USD
Upside/Downside 85%
View Source
Scott Schoenhaus
KeyBanc
Price Target 7 USD
Upside/Downside 159%
View Source
Abcellera Biologics Inc Competitors:
Price Targets
603259
WuXi AppTec Co Ltd
24% Upside
TECH
Bio-Techne Corp
11% Upside
PSNL
Personalis Inc
66% Upside
DIVISLAB
Divi's Laboratories Ltd
23% Downside
SKAN
SKAN Group AG
19% Upside
688114
MGI Tech Co Ltd
5% Upside
NANOFH
Nanoform Finland Oyj
222% Upside
SEER
Seer Inc
38% Upside

Revenue
Forecast

Revenue Estimate
Abcellera Biologics Inc

For the last 4 years the compound annual growth rate for Abcellera Biologics Inc's revenue is 35%. The projected CAGR for the next 3 years is 32%.

35%
Past Growth
32%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Abcellera Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Abcellera Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABCL's stock price target?
Price Target
15.74 USD

According to Wall Street analysts, the average 1-year price target for ABCL is 15.74 USD with a low forecast of 5.05 USD and a high forecast of 29.4 USD.

What is Abcellera Biologics Inc's Revenue forecast?
Projected CAGR
32%

For the last 4 years the compound annual growth rate for Abcellera Biologics Inc's revenue is 35%. The projected CAGR for the next 3 years is 32%.

Back to Top